Merakris Therapeutics, a clinical-stage Research Triangle Park regenerative biologic medicines company, has received a $2.2 million federal grant to advance commercialization of a diabetic food ulcer ...
Opportunity had plenty of doors to knock on at ConvergeSouth 2026, held August 27-28 in downtown Winston-Salem’s Innovation Quarter. More than 500 enthusiastic entrepreneurs, investors and support ...
Digital healthcare firm Higgs Boson Health, a Durham-based portfolio company of the North Carolina Biotechnology Center, has been acquired by Globus Medical. Higgs Boson Health's technology and staff ...
Cambrex’s inspection approvals follow the company’s $38 million expansion of the High Point facility completed in 2023. The expansion added analytical and chemical development laboratories, a clinical ...
By all accounts, the approach works. QHP has $4.5 billion in assets under management, and its newest fund, the NovaQuest Private Equity Fund II, raised $500 million in 2022, exceeding its target of ...
Innatrix Inc., a Durham-based agricultural biotechnology company developing sustainable biological crop protection solutions, was awarded a $499,786 Small Business Innovation Research (SBIR) Phase IIB ...
We won't track your information when you visit our site. But in order to comply with your preferences, we'll have to use just one tiny cookie so that you're not asked to make this choice again.
NCBiotech's Military Outreach and Veterans Engagement (MOVE) Boots to Biotech program connects transitioning service members, veterans, and military spouses to meaningful, high-impact careers in North ...
“Miracle Road” is the quintessential diary of what, how, and especially who made RTP what it is today, with some closing observations and suggestions about what might come. A public book-launch event ...
Join Innovate Carolina on September 10 for a seminar discussing NCInnovation's grant program for faculty innovators.
Eight of the top 10 largest pharma companies (based on 2025 revenue) will have operations in North Carolina, including AbbVie, AstraZeneca, Johnson & Johnson, Lilly, Merck, Pfizer, Roche/Genentech and ...
CorestemChemon, a biopharmaceutical company headquartered in South Korea, has begun U.S. operations based in Winston-Salem’s Innovation Quarter. The company’s U.S. subsidiary, CorestemChemon US Inc., ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results